Gaydarski Lyubomir, Georgiev Georgi P, Slavchev Svetoslav A
Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria.
Department of Orthopedics and Traumatology, University Hospital Queen Giovanna-ISUL, Medical University of Sofia, 1431 Sofia, Bulgaria.
Reports (MDPI). 2025 Jul 17;8(3):112. doi: 10.3390/reports8030112.
Neurofibromatosis type 1 (NF1) predisposes individuals to various peripheral nerve sheath tumors (PNSTs), including benign neurofibromas, malignant peripheral nerve sheath tumors (MPNSTs), and intermediate lesions known as atypical neurofibromatous neoplasms of uncertain biologic potential (ANNUBP), previously often termed atypical neurofibroma. These atypical lesions are considered premalignant precursors to MPNST. We present the case of a 33-year-old male with NF1 who developed a rapidly growing, painful mass in his right calf. Clinical examination revealed signs consistent with NF1. Magnetic resonance imaging showed a large, heterogeneous mass in the lateral compartment. Biopsy revealed a neurofibroma with hypercellularity, moderate atypia, scarce S100 positivity, focal CD34 positivity, and an elevated Ki-67 proliferation index of 10-12%, consistent with ANNUBP. The patient underwent wide surgical resection, including the fibula and peroneal muscles. At the 30-month follow-up, there was no local recurrence, though the patient had a mild residual limp. This case highlights the clinical presentation, diagnostic features, and management considerations for ANNUBP in NF1, emphasizing the importance of recognizing warning signs and the role of pathology in guiding treatment for these high-risk precursor lesions.
1型神经纤维瘤病(NF1)使个体易患各种周围神经鞘瘤(PNST),包括良性神经纤维瘤、恶性周围神经鞘瘤(MPNST)以及生物学潜能不确定的非典型神经纤维瘤性肿瘤(ANNUBP)等中间性病变,ANNUBP以前常被称为非典型神经纤维瘤。这些非典型病变被认为是MPNST的癌前病变。我们报告一例33岁患有NF1的男性患者,其右小腿出现一个快速生长的疼痛性肿块。临床检查发现与NF1相符的体征。磁共振成像显示外侧肌间隔有一个大的、不均匀的肿块。活检显示为神经纤维瘤,细胞增多、中度异型性、S100阳性少见、局灶性CD34阳性,Ki-67增殖指数升高至10 - 12%,符合ANNUBP。患者接受了包括腓骨和腓骨肌的广泛手术切除。在30个月的随访中,虽患者有轻度残留跛行,但无局部复发。本病例突出了NF1中ANNUBP的临床表现、诊断特征及治疗考量,强调了识别警示信号的重要性以及病理学在指导这些高危癌前病变治疗中的作用。